参考文献/References:
[1] KITAMURA N,SHIRAIWA H,INOMATA H,et al.Efficacy and safety of minodronic acid hydrate in patients with steroid-induced osteoporosis[J].Int J Rheum Dis,2018,21(4):813-820.DOI:10.1111/1756-185X.12844.
[2] 宋伟杰,曾皓月,龙莎,等.采用原研制剂制备米诺膦酸片及体外溶出度的一致性考察[J].华侨大学学报(自然科学版),2018,39(1):70-74.DOI:10.11830/ISSN.1000-5013.201706032.
[3] TANAKA M,HOSOYA A,MORI H,et al.Minodronic acid induces morphological changes in osteoclasts at bone resorption sites and reaches a level required for antagonism of purinergic P2X2/3 receptors[J].J Bone Miner Metab,2018,36(1):54-63.DOI:10.1007/s00774-017-0814-y.
[4] TAGUCHI A,UEMURA Y,IMAI T,et al.Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid[J].J Bone Miner Metab,2019,37(5):886-892.DOI:10.1007/s00774-019-00990-5.
[5] DUNFORD J E,THOMPSON K,COXON F P,et al.Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates[J].J Pharmacol Exp Ther,2001,296(2):235-242.
[6] 华小懿,沈于兰,杨敏智.离子色谱法测定米诺膦酸及其片剂的含量[J].中国药品标准,2019,20(2):138-142.DOI:10.19778/j.chp.2019.02.008.
[7] 宋伟杰,周玥莹,王立强,等.高效液相色谱法测定米诺膦酸的含量及有关物质[J].中国新药杂志,2018,27(16):1932-1938.
[8] 邬方宁.高效液相色谱法测定米诺膦酸片中米诺膦酸[J].现代药物与临床,2011,26(1):66-67.
[9] 邵宪伟.米诺膦酸的合成工艺研究[D].北京:北京化工大学,2017.
[10] 赵世明,李玲,韩世磊,等.米诺膦酸的合成[J].中国新药杂志,2014,23(11):1307-1310.
[11] 吴素平,蔡玲,金坚,等.顶空气相色谱法检测米诺膦酸中残留溶剂[J].中国新药杂志,2016,25(24):2839-2842.
[12] 张巍,蔡犇,李范珠.顶空气相色谱法测定依帕司他有机溶剂残留量[J].中国现代应用药学.2017,34(9):1286-1288.DOI:10.13748/j.cnki.issn1007-7693.2017.09.015.
[13] 裴丽娟,田晨,齐然然,等.顶空气相色谱法同时测定布南色林原料药中9种有机溶剂的残留量[J].中国药房,2017,28(12):1699-1702.DOI:10.6039/j.issn.1001-0408.2017.12.32.
[14] 袁淑杰.新型杂环双膦酸类化合物米诺膦酸的合成新工艺研究[J].中国医药指南,2015,13(5):291-292.DOI:10.15912/j.cnki.gocm.2015.05.220.
[15] RYAN A E.Protecting the rights of pediatric research subjects in the international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use[J].Fordham International Law Journal.2000,23(3):848-934.DOI:10.1007/s11270-010-0628-1.
[16] 国家药典委员会.中华人民共和国药典: 四部(2020年版)[M].北京:中国医药科技出版社,2020.